APA (7th ed.) Citation

DJ, J., H, B., H, R., PE, P., IJ, C., S, F., . . . AM, N. (2024). Overcoming Barriers to Remission in Severe Eosinophilic Asthma: Two-Year Real-World Data With Benralizumab. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 54(10), 734. https://doi.org/10.1111/cea.14544

Chicago Style (17th ed.) Citation

DJ, Jackson, et al. "Overcoming Barriers to Remission in Severe Eosinophilic Asthma: Two-Year Real-World Data With Benralizumab." Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology 54, no. 10 (2024): 734. https://doi.org/10.1111/cea.14544.

MLA (9th ed.) Citation

DJ, Jackson, et al. "Overcoming Barriers to Remission in Severe Eosinophilic Asthma: Two-Year Real-World Data With Benralizumab." Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology, vol. 54, no. 10, 2024, p. 734, https://doi.org/10.1111/cea.14544.